Yan Chen1, Qianqian Guan2, Xiuyuan Feng1 , Xuejun Jiang3, Guang Xu1, Hongwei Hou1 BiKe 1
1Department of Cardiology, Ezhou Central Hospital, Ezhou; 2Department of Cardiology, Puren Hospital of Wuhan; 3Department of Cardiology, Hubei Provincial People's Hospital, Wuhan, Hubei Province 43000, China.For correspondence:- Xiuyuan Feng Email: fengxiuyuan666@163.com Tel:+862760660503
Accepted: 28 February 2021 Published: 31 March 2021
Citation: Chen Y, Guan Q, Feng X, Jiang X, Xu G, Hou H, et al. LINC-ROR regulates myocardial ischemia/reperfusion injury via targeting of miR-129-5p/Hook3 axis. Trop J Pharm Res 2021; 20(3):445-451 doi: 10.4314/tjpr.v20i3.1
© 2021 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..
Results: LINC-ROR was elevated under H/R stimulation. The viability of H9C2 cells decreased, and cell apoptosis was induced after H/R treatment. These latter effects were abrogated by the down-regulation of LINC-ROR. Luciferase reporter results and RNA pull-down showed that LINC-ROR served as the miR-129-5p sponge, and miR-129-5p was bound to Hook3 RNA directly. Moreover, overex Conclusion: LINC-ROR increases in cardiomyocytes with H/R injury. Down-regulation of LINC-ROR alleviates myocardial I/R injury via miR-129-5p/Hook3 axis. Therefore, LINC-ROR is a potential therapeutic target for myocardial I/R injury.
Archives
News Updates